29973-97-5

29973-97-5 structure

Name: 2-[3-(Benzyloxy)phenyl]ethanamine hydrochloride (1:1)
Chemical Name: 2-[3-(Benzyloxy)phenyl]ethanamine hydrochloride (1:1)
CAS Number: 29973-97-5
Molecular Formula: C₁₅H₁₈ClNO
Molecular Weight: 263.76300
Create Date: 2018-07-11 21:35:37
Modify Date: 2024-01-10 13:47:51

Name	2-[3-(Benzyloxy)phenyl]ethanamine hydrochloride (1:1)
Synonyms	2-(3-(benzyloxy)phenyl)-2-methylpropanal 2-(3-Benzyloxyphenyl)-2-methylpropionaldehyd 3-Benzyloxy-phenaethylamin,Hydrochlorid 2-<3-(benzyloxy)phenyl>-2-methylpropionaldehyde \|A,\|A-Dimethyl-3-(phenylmethoxy)benzeneacetaldehyde 3-benzyloxyphenethylamine hydrochloride 2-(3-benzyloxy-phenyl)-ethylamine hydrochloride

Boiling Point	370.1ºC at 760mmHg
Molecular Formula	C₁₅H₁₈ClNO
Molecular Weight	263.76300
Flash Point	179.3ºC
Exact Mass	263.10800
PSA	35.25000
LogP	4.26910
Vapour Pressure	1.13E-05mmHg at 25°C

CHEMICAL IDENTIFICATION

RTECS NUMBER :: DA0341600

CHEMICAL NAME :: Benzeneethanamine, 3-(phenylmethoxy)-, hydrochloride

CAS REGISTRY NUMBER :: 29973-97-5

LAST UPDATED :: 199112

DATA ITEMS CITED :: 1

MOLECULAR FORMULA :: C15-H17-N-O.Cl-H

MOLECULAR WEIGHT :: 263.79

HEALTH HAZARD DATA

ACUTE TOXICITY DATA

TYPE OF TEST :: LD50 - Lethal dose, 50 percent kill

ROUTE OF EXPOSURE :: Intraperitoneal

SPECIES OBSERVED :: Rodent - mouse

DOSE/DURATION :: 164 mg/kg

TOXIC EFFECTS :: Behavioral - convulsions or effect on seizure threshold

REFERENCE :: RPTOAN Russian Pharmacology and Toxicology (English Translation). Translation of FATOAO. (Euromed Pub., 33, Woodlands Rd., Surbiton, Surrey, UK) V.30- 1967- Volume(issue)/page/year: 39,209,1976

24550-32-1

29973-97-5

Literature: Conte-Mayweg, Aurelia; Kuehne, Holger; Luebbers, Thomas; Maugeais, Cyrille; Mueller, Werner; Pflieger, Philippe Patent: US2006/30613 A1, 2006 ; Location in patent: Page/Page column 22 ;

20967-96-8

29973-97-5

Literature: Baxter, Ellen W.; Reitz, Allen B.; Parker, Michael H.; Huang, Yifang; Ho, Chih Yung; Strobel, Eric D.; Reynolds, Charles H. Patent: US2007/232630 A1, 2007 ; Location in patent: Page/Page column 18 ; US 20070232630 A1

588-05-6

29973-97-5

Literature: Rigel Pharmaceuticals, Inc.; Goff, Dane; Payan, Donald G.; Braselmann, Sylvia Patent: US2013/237524 A1, 2013 ;

2039-67-0

29973-97-5

Literature: Santangelo Freel, Rose M.; Ogden, Kevin K.; Strong, Katie L.; Khatri, Alpa; Chepiga, Kathryn M.; Jensen, Henrik S.; Traynelis, Stephen F.; Liotta, Dennis C. Journal of Medicinal Chemistry, 2013 , vol. 56, # 13 p. 5351 - 5381

38449-59-1

29973-97-5

Precursor 5
24550-32-1 20967-96-8 588-05-6 2039-67-0
38449-59-1
DownStream 1
51061-22-4

1893704-01-2	1890717-64-2
1442085-46-2	1956364-60-5
1778951-69-1	1806806-94-9
1805321-65-6	1603356-81-5
1597049-74-5	1888598-26-2